324 Dose-seeking phase I trials (DSPT) of approved molecularly targeted therapies (MTT): Exhaustiveness and readability of published clinical reports. (September 2015) - Cousin, S.; Hollebecque, A.; Isambert, N.; Italiano, A.; Kotecki, N.; Postel-Vinay, S.; Gobbo, J.; Toulmonde, M.; Penel, N.